rTR Technovation Corporation
生物技术研究
Monrovia,CA 89 位关注者
“Realizing Technological Innovations from Reverse Translational Research of Disease Remissions”
关于我们
Our mission is to develop technology to research rare cases of disease remission and ultimately mimic those responses. To achieve this, we developed a versatile nanoparticle platform for diagnostic and therapeutic use. Its unique design enables the earliest and most sensitive detection of disease-prone blood vessels, associated with various chronic diseases, such as heart disease, cancer, and diabetes.
- 所属行业
- 生物技术研究
- 规模
- 1 人
- 总部
- Monrovia,CA
- 类型
- 上市公司
- 创立
- 2019
地点
-
主要
US,CA,Monrovia,91016
rTR Technovation Corporation员工
-
Kevin Stealey
Commercial Focused Leader who accelerates and scales profitable growth. ex P&G, ex TMO. | Author | Speaker
-
Dr. Ashok Srivastava, MD, Ph.D., MBA, 博士. アショク スリヴァスタワ
Senior Vice President, Chief Clinical Officer, Oncology, Hematology, Rare Cancers; Clinical Strategy, Clinical Trial Metastatic Solid & Hematologic…
-
Paul Lee